Related Experiment Video

Updated: Aug 8, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Cardiovascular disease in children with chronic renal failure

Joseph T Flynn1

  • 1Department of Pediatrics, Division of Pediatric Nephrology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA. jflynn@montefiore.org

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|May 16, 2006
PubMed

Insights

Cardiovascular disease (CVD) is a major concern for children with chronic kidney disease (CKD). Research indicates CVD is a leading cause of death in these young patients, highlighting the need for effective interventions.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Medicine
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a primary cause of death in adults with chronic kidney disease (CKD).
  • Emerging evidence shows significant cardiovascular complications in pediatric patients with CKD.
  • Studies confirm CVD as a leading cause of mortality in young adults with childhood-onset CKD.

Purpose of the Study:

  • To investigate the prevalence and impact of cardiovascular disease (CVD) in children and young adults with chronic kidney disease (CKD).
  • To identify key risk factors contributing to CVD in pediatric CKD patients.
  • To inform the development of targeted interventions for reducing cardiovascular risk in this population.

Main Methods:

  • Prospective observational study design.
  • Enrollment of a large cohort of children with chronic kidney disease (CKD).
  • Monitoring of cardiovascular events and risk factors over time.

Main Results:

  • Cardiovascular disease (CVD) is a significant cause of morbidity and mortality in pediatric CKD patients.
  • Hypertension, dyslipidemia, anemia, and abnormal calcium-phosphorus metabolism are prevalent risk factors.
  • Data on the efficacy of interventions in pediatric CKD are currently lacking.

Conclusions:

  • Cardiovascular complications pose a serious threat to children and young adults with chronic kidney disease (CKD).
  • Further research, including large-scale studies, is crucial to understand CVD progression and effective treatments in pediatric CKD.
  • Early identification and management of risk factors are essential for improving outcomes.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...